Who We Are
➤Academic Partnerships
IRAZÚ partners with individual Principal Investigators and university-based Centers of Excellence to accelerate translational research into IND-enabling studies and Phase 1 clinical trials
➤Research Curation
IRAZÚ increases value for transformative, vetted intellectual property assets with a hands -on approach
➤Business Model
IRAZÚ either licenses with pharma companies for clinical development of lower risk, higher value IP assets or starts new companies in collaboration with venture capital groups
Contact
➤ LOCATION
801 W. Baltimore Street, Suite 518
Baltimore, MD 21201
☎ CONTACT
info@irazubio.com
(443) 396-8666
Focus Areas
Arctic Ground Squirrel (Spermophilus parryii)
Hypoxia Tolerance And NeuroProtectION
IRAZÚ leverages biochemical mechanisms found in nature. These include caloric restriction models, newborn mammals and hibernators that are known to be neuroprotected and hypoxia tolerant. Practical applications may promote survival, prevent disease and improve the quality of life in old age.
Kras-Driven Lung Cancer. Photo by National Cancer Institute on Unsplash
Immuno-Oncology
IRAZÚ partners with lead research labs to develop “Bugs as Drugs” in treating various cancers. We apply a platform to induce global immunity targeting unique tumor antigens.
Adeno-Associated Virus (AAV)
Gene Therapy
IRAZÚ’s team has a deep background in gene therapy process development and manufacturing of Adeno-Associated Virus (AAV). We seek new projects and partners to develop new gene therapies for rare and orphan diseases.
Our Team
